Literature DB >> 17159798

Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot.

Ján Vojtassák1, L'ubos Danisovic, Miroslav Kubes, Dusan Bakos, L'ubomír Jarábek, Marcela Ulicná, Milan Blasko.   

Abstract

OBJECTIVES: This study was performed to test a new technique for treatment of chronic non-healing wound (diabetic ulcer) using autologous biograft composed of autologous skin fibroblasts on biodegradable collagen membrane (Coladerm) in combination with autologous mesenchymal stem cells (MSC) derived from the patient's bone marrow.
DESIGN: The bone marrow aspirate of the patient with diabetic foot was applied directly to the wound and injected into the edges of the wound, finally covered with prepared autologous biograft. The patient received two additional treatments with cultured MSC on day 7 and 17.
RESULTS: The wound showed a steady overall decrease in wound size and an increase in the vascularity of the dermis and in the dermal thickness of the wound bed after 29 days of combined treatment.
CONCLUSIONS: Closing and healing of the non-healing diabetic ulcer was achieved by using the given combined therapy.

Entities:  

Mesh:

Year:  2006        PMID: 17159798

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  54 in total

Review 1.  Comprehensive review of the clinical application of autologous mesenchymal stem cells in the treatment of chronic wounds and diabetic bone healing.

Authors:  Gerit D Mulder; Daniel K Lee; Nathan S Jeppesen
Journal:  Int Wound J       Date:  2012-02-28       Impact factor: 3.315

Review 2.  Genetic engineering of mesenchymal stem cells and its application in human disease therapy.

Authors:  Conrad P Hodgkinson; José A Gomez; Maria Mirotsou; Victor J Dzau
Journal:  Hum Gene Ther       Date:  2010-10-22       Impact factor: 5.695

Review 3.  Stem cells for skin tissue engineering and wound healing.

Authors:  Ming Chen; Melissa Przyborowski; Francois Berthiaume
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 4.  The Role of Chemokines in Mesenchymal Stem Cell Homing to Wounds.

Authors:  Anne M Hocking
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

5.  Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus.

Authors:  Qing Lin; Russell N Wesson; Hiromichi Maeda; Yongchun Wang; Zhu Cui; Jun O Liu; Andrew M Cameron; Bin Gao; Robert A Montgomery; George M Williams; Zhaoli Sun
Journal:  J Invest Dermatol       Date:  2014-03-28       Impact factor: 8.551

6.  Therapeutic potential of gingival fibroblasts for cutaneous radiation syndrome: comparison to bone marrow-mesenchymal stem cell grafts.

Authors:  Christine Linard; Frederique Tissedre; Elodie Busson; Valerie Holler; Thomas Leclerc; Carine Strup-Perrot; Ludovic Couty; Bruno L'homme; Marc Benderitter; Antoine Lafont; Jean Jacques Lataillade; Bernard Coulomb
Journal:  Stem Cells Dev       Date:  2015-02-26       Impact factor: 3.272

Review 7.  Concise review: role of mesenchymal stem cells in wound repair.

Authors:  Scott Maxson; Erasmo A Lopez; Dana Yoo; Alla Danilkovitch-Miagkova; Michelle A Leroux
Journal:  Stem Cells Transl Med       Date:  2012-02       Impact factor: 6.940

Review 8.  Insights into bone marrow-derived mesenchymal stem cells safety for cutaneous repair and regeneration.

Authors:  Y Wu; S Huang; J Enhe; X Fu
Journal:  Int Wound J       Date:  2012-08-30       Impact factor: 3.315

Review 9.  The role of adult tissue-derived stem cells in chronic leg ulcers: a systematic review focused on tissue regeneration medicine.

Authors:  Bruno Amato; Rita Compagna; Maurizio Amato; Lucia Butrico; Francesco Fugetto; Mariia D Chibireva; Andrea Barbetta; Marco Cannistrà; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2015-09-24       Impact factor: 3.315

Review 10.  The potential of cell-based therapy for diabetes and diabetes-related vascular complications.

Authors:  Aaron Liew; Timothy O'Brien
Journal:  Curr Diab Rep       Date:  2014-03       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.